Silybin and the liver: From basic research to clinical practice

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 18

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

1176

HTML

16331

Tables (1-9)

230

Sum=17737

May 14, 2011 (publication date) through Sep 23, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. May 14, 2011; 17(18): 2288-2301
Published online May 14, 2011. doi: 10.3748/wjg.v17.i18.2288

Table 5 Antioxidant effects of silybin[65-75]

Doses	Cells	Targets
From 10 to 100 μmol/L	Hepatocytes	Decreased formation of reactive oxygen species from mitochondria; iron chelator
From 10 to 100 μmol/L	HepG2	Decreased formation of superoxide anion
Mean dose with documented effects: 20 μmol/L	Kupffer cells	Decrease of NO production
	Monocytes	Scavenger of lipodienyl, methyl, trichloromethyl radicals
	Endothelial cells	Decrease of hydrogen peroxide concentration
	Cancer cells	Block of membrane lipid peroxidation

Citation: Loguercio C, Festi D. Silybin and the liver: From basic research to clinical practice. World J Gastroenterol 2011; 17(18): 2288-2301
URL: https://www.wjgnet.com/1007-9327/full/v17/i18/2288.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i18.2288